Corestreet Logo

NGM Biopharmaceuticals Inc (NGM) Insider Trading

Total insider buys:
  • $111,720,295.34
Total insider sells:
  • $11,048,041.52
Most recent insider trade:
  • Jan. 30, 2023
Most active insider trader:
  • Group L P Column
Trader NameDateTitleAmountPriceTypeTotal Value
March 31, 2020Director118,067$12.53Buy$1,479,379.51
March 25, 2020Director2,416$12.49Buy$30,175.84
March 25, 2020Major Shareholder301,180$13.33Buy$4,014,729.40
March 23, 2020Director170,387$11.63Buy$1,981,600.81
March 20, 2020Major Shareholder143,082$11.77Buy$1,684,075.14
March 19, 2020Director148,464$11.59Buy$1,720,697.76
March 5, 2020Director8,307$18.00Buy$149,526.00
March 4, 2020Major Shareholder9,986$17.96Buy$179,348.56
March 3, 2020Director38,758$17.99Buy$697,256.42
March 2, 2020Major Shareholder14,124$17.90Buy$252,819.60
Feb. 28, 2020Major Shareholder75,447$18.04Buy$1,361,063.88
Feb. 27, 2020Director33,896$17.91Buy$607,077.36
Feb. 26, 2020Major Shareholder3,751$18.00Buy$67,518.00
Feb. 6, 2020Major Shareholder44,900$15.47Buy$694,603.00
Jan. 9, 2020Insider18,641$17.95Sell$334,605.95
Jan. 7, 2020Insider16,090$18.20Sell$292,838.00
Nov. 11, 2019Director15$12.00Buy$180.00
Nov. 4, 2019Insider50,765$12.67Sell$643,192.55
Nov. 4, 2019Director8,409$13.01Buy$109,401.09
Oct. 23, 2019Director4,387$13.54Buy$59,399.98
Oct. 21, 2019Major Shareholder30,926$77.72Sell$2,403,568.72
Oct. 21, 2019Director84,939$11.75Buy$998,033.25
Oct. 16, 2019Director11,000$3.10Buy$34,100.00
Oct. 16, 2019Major Shareholder103,000$10.87Buy$1,119,610.00
Oct. 14, 2019Major Shareholder20,000$1.41Sell$28,200.00
Oct. 11, 2019Major Shareholder53,172$10.38Buy$551,925.36
Aug. 9, 2019Major Shareholder224,664$14.00Buy$3,145,296.00
Aug. 6, 2019Director6,134$13.98Buy$85,753.32
Aug. 2, 2019Major Shareholder4,382$13.98Buy$61,260.36
July 30, 2019Director28,056$13.68Buy$383,806.08
July 26, 2019Director89,866$13.49Buy$1,212,292.34
July 23, 2019Major Shareholder67,742$13.49Buy$913,839.58
July 16, 2019Major Shareholder20,088$13.72Buy$275,607.36
July 12, 2019Major Shareholder31,884$13.88Buy$442,549.92
June 24, 2019Major Shareholder12,240$13.78Buy$168,667.20
June 21, 2019Major Shareholder34,377$13.90Buy$477,840.30
June 14, 2019Director29,760$14.05Buy$418,128.00
June 11, 2019Major Shareholder23,500$13.74Buy$322,890.00
June 6, 2019Major Shareholder25,200$13.40Buy$337,680.00
May 20, 2019Major Shareholder50,000$13.50Buy$675,000.00
May 10, 2019Major Shareholder17,923$13.85Buy$248,233.55
May 7, 2019Director57,000$14.10Buy$803,700.00
April 8, 2019Major Shareholder4,121,683$16.00Buy$65,946,928.00
April 8, 2019Director7,000$16.00Buy$112,000.00
First«2 of 2»Last

  • Insiders are both buying and selling NGM Biopharmaceuticals Inc stock.

  • The insider traders at NGM Biopharmaceuticals Inc are: Group L P Column, Jin-Long Chen, Peter Svennilson, David V Goeddel, David J Woodhouse, Suzanne Sawochka Hooper, Hsiao D Lieu, Hsiao D. Lieu, and Merck & Co., Inc.

  • The most active insider trader at NGM Biopharmaceuticals Inc is Group L P Column with 51 trades.

  • Jin-Long Chen has sold the most NGM Biopharmaceuticals Inc stock with a total value of $8,675,781.10.

  • Merck & Co., Inc. has bought the most NGM Biopharmaceuticals Inc stock with a total value of $131,893,856.00.

  • The most recent insider trade for NGM Biopharmaceuticals Inc was on Jan. 30, 2023.

  • The single biggest insider buy for NGM Biopharmaceuticals Inc was from Merck & Co., Inc. with a total value of $65,946,928.00 on April 8, 2019.

  • The single biggest insider sell for NGM Biopharmaceuticals Inc was from Group L P Column with a total value of $2,403,568.72 on Oct. 21, 2019.